(AQs), including HQNO, enable P. aeruginosa to outcompete other bacterial species in its environment, particularly S. aureus, according to OglesbySherrouse. "Both bacterial species must be cultured together for this phenomenon to occur, as you can't just provide culture supernatant from P. aeruginosa to block growth of S. aureus," she says. "This indicates that P. aeruginosa must sense S. aureus." Previously, she notes, most of what is known about iron regulation in bacterial species was learned from studies of bacteria grown in pure cultures.
"These two papers . . . give some of the fırst evidence regarding how host micronutrients [affect] interactions of two prevalent CF pathogens and provide insights into the mechanism controlling P. aeruginosa-mediated succession in the CF lung," note Patricia M. Barnabie and Marvin Whiteley of the University of Texas, Austin, in the commentary that accompanies the two reports. "The control of such hostmodulated bacterial interactions is thus a largely unexplored fıeld that may one day prove a fertile ground for medical innovation." David C. Holzman is the Microbe Journal Highlights Editor.
NEW IN ASM JOURNALS

Fungus Sequesters Industrially Valuable Rare-Earth Elements Carol Potera
A newly identifıed fungal species, isolated from an abandoned mine, can concentrate dysprosium and other industrially valuable rare-earth elements-making this fungus potentially useful for recovering such materials, according to Takumi Horiike and Mitsuo Yamashita at Shibaura Institute of Technology in Saitama, Japan. This fungus, which they are calling Penidiella sp. T9, appears to be the fırst microorganism known to recover rareearth elements during cell growth, they report. Details appeared 1 May 2015 in Applied Environmental Microbiology (doi:10.1128/AEM.00300 -15).
The rare-earth element dysprosium, which is strongly magnetic and thus used widely in cell phones, wind turbines, and hybrid automobiles, can contaminate industrial and mining sites. With that information in mind, the researchers collected sediment and liquid samples from a total of 72 abandoned mines, industrial waste sites, and waste disposal plants throughout Japan. They then incubated each of the samples in an acidifıed culture medium that was spiked with dysprosium, providing conditions similar to those where this element is mined.
Penidiella sp. T9 grew in one of those samples, taking up about 50% of the dysprosium from the medium when cultivated for several days at pH 2.5. In addition to taking up dysprosium, Penidiella sp. T9 takes up and concentrates several other rare-earth elements, including 52% of praseodymium, 50% of neodymium, 45% of terbium, and 38% of europium. However, this rod-shaped fungus does not require dysprosium for growth, leaving unanswered the question of what advantage it gains from accumulating this or other rare-rearth elements.
After they tinkered with culture conditions, Penidiella sp. T9 becomes even more profıcient at taking up dysprosium, according to Horiike and Yamashita. Moreover, the process can be scaled up in the laboratory to work in 100-liter reactors. "We hope to construct a combination process for the bioaccumulation and purifıcation of dysprosium," Horiike says.
"Fungi are unappreciated, but highly signifıcant, geoactive agents in a wide range of environments, and their vast geodiversity is understudied," says Geoff Gadd at the University of Dundee in Scotland. "This fascinating work provides a strong rationale for further geomycological research on the remarkable properties and applications of fungi in environmental biotechnology." Moreover, Penidiella's geochemical properties are relevant to recovering this element, bioremediating sites where it is a contaminant, and for producing novel inorganic biomaterials.
Dysprosium is considered the single most critical element for some kinds of clean energy production technology, according to offıcials of the U.S. Department of Energy. Most dysprosium is mined in China, and prices soared
MINITOPIC
Historian Disputes Claims about Smallpox Role in Early America
The idea that Europeans used smallpox and other infectious diseases deliberately to take advantage of Native Americans is "very problematic," and it is based mainly on anecdotal evidence, says historian Paul Kelton of the University of Kansas, Lawrence. He argues, for example, that the Cherokee people took steps, including efforts to establish quarantines, to protect themselves against smallpox, but that the overrunning of their villages kept such measures from being effective. "Smallpox did not shatter Native belief systems and destroy their medicine as is so often depicted in the literature," he says. "What I hope is that my answer to this difficult question will encourage us today to put contemporary experience with infectious diseases in a larger historical context, one in which imperialism and colonialism-not independent actions of microbes acting alone-have created terrible health disparities around the globe." Kelton's book, Cherokee Medicine, Colo- from $7 per pound in 2003 to $130 per pound in 2010. A low-cost process for recovering dysprosium from mining sites and contaminated water at industrial sites could increase its supply and reduce costs. With current concerns over sustaining the supply of dysprosium and other valuable rare-earth elements required for clean energy technology, "fungal systems have a clear potential for the immobilization and biorecovery of these important substances," Gadd says.
There are precedents for using microorganisms on an industrial scale to recover metals and radioactive elements, according to Gadd. Sulfate-reducing bacteria are used to precipitate and recover metals such as zinc in a commercial system available through Paques BV, headquartered in the Netherlands. Other industrial-scale systems rely on acidophilic bacteria to make sulfuric acid for leaching copper, gold, and uranium, he says. Amid interest in fınding microbes to recycle rare-earth elements, he adds, "so far there are no industrial processes."
Carol Potera is a freelance writer in Great Falls, Mont.
RESEARCH ADVANCES
Outbreak Spurred Several Approaches to Developing Ebola Therapeutic Products Jeffrey L. Fox
Several distinct types of Ebola therapeutic products are under development-some more or less conventional antiviral agents, while others depend on more recently developed techniques to disrupt viral gene activity or use antibodies to bind the virus and trigger host immune responses.
Some DoD continues to support the RNA silencing candidate products that Tekmira is developing, including its lead candidate, TKM-Ebola-Guinea, which was adjusted to accommodate minor sequence changes in the genome of the viral strain that circulated in West Africa during the outbreak. The lipid-encapsulated siRNA "triggers" target the genes VP35 and L polymerase of the Ebola virus, which function in viral replication and, in the case of VP35, also in blocking the host immune response to the virus, according to Tekmira.
Meanwhile, several mixtures containing specifıc monoclonal antibodies (mAbs)-typically, two or more mAbs aimed at more than one target on the Ebola virus-are now being evaluated as therapeutic products. Treatment results are anecdotal, but similar mixtures of these mAbs seem to be having an effect in patients infected with the Ebola virus, according to Gary Kobinger of the National Microbiology Laboratory in Winnipeg, Canada, part of the Public Health Agency of Canada (PHAC).
Prominent among these candidates
The rare-earth element dysprsium contaminates industrial and mining sites. Researchers were able to isolate a fungal species, Penidiella sp. T9, that takes up and concentrates dysprosium and other rare-earth elements from such sites. (Image © slovegrove/iStockphoto.).
